JP2020505334A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020505334A5 JP2020505334A5 JP2019537154A JP2019537154A JP2020505334A5 JP 2020505334 A5 JP2020505334 A5 JP 2020505334A5 JP 2019537154 A JP2019537154 A JP 2019537154A JP 2019537154 A JP2019537154 A JP 2019537154A JP 2020505334 A5 JP2020505334 A5 JP 2020505334A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- monoclonal antibody
- antibody according
- amino acid
- chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022130651A JP7461420B2 (ja) | 2017-01-06 | 2022-08-18 | 治療抗ＩｇＥ抗体並びにその方法及び組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762443547P | 2017-01-06 | 2017-01-06 | |
| US62/443,547 | 2017-01-06 | ||
| PCT/US2018/012479 WO2018129248A1 (en) | 2017-01-06 | 2018-01-05 | Therapeutic anti-ige antibodies and methods and compositions thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022130651A Division JP7461420B2 (ja) | 2017-01-06 | 2022-08-18 | 治療抗ＩｇＥ抗体並びにその方法及び組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020505334A JP2020505334A (ja) | 2020-02-20 |
| JP2020505334A5 true JP2020505334A5 (cg-RX-API-DMAC7.html) | 2021-02-04 |
| JP7128191B2 JP7128191B2 (ja) | 2022-08-30 |
Family
ID=62789396
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019537154A Active JP7128191B2 (ja) | 2017-01-06 | 2018-01-05 | 治療抗ＩｇＥ抗体並びにその方法及び組成物 |
| JP2022130651A Active JP7461420B2 (ja) | 2017-01-06 | 2022-08-18 | 治療抗ＩｇＥ抗体並びにその方法及び組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022130651A Active JP7461420B2 (ja) | 2017-01-06 | 2022-08-18 | 治療抗ＩｇＥ抗体並びにその方法及び組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US11518818B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3565587A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7128191B2 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2018205484B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3049967C (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018129248A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020154627A1 (en) * | 2019-01-25 | 2020-07-30 | Promab Biotechnologies, Inc. | Epcam antibody and epcam-car-t cells |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2296839T3 (es) * | 1991-08-14 | 2008-05-01 | Genentech Inc. | Variantes de inmunoglobulinas para receptores fc-epsilon especificos. |
| US6685939B2 (en) | 1991-08-14 | 2004-02-03 | Genentech, Inc. | Method of preventing the onset of allergic disorders |
| HK1048127A1 (en) | 2000-01-14 | 2003-03-21 | Daiichi Pharmaceutical Co., Ltd. | Novel peptide and screening method by using the same |
| AU7658101A (en) | 2000-07-28 | 2002-02-13 | Cytos Biotechnology Ag | Compositions for inducing self-specific anti-ige antibodies and uses thereof |
| US20050169909A1 (en) * | 2004-02-02 | 2005-08-04 | Sanjaya Singh | Identification of novel IgE epitopes |
| CA2514840C (en) | 2003-02-01 | 2017-11-07 | Tanox, Inc. | High affinity, anti-human ige antibodies |
| KR101581659B1 (ko) | 2004-02-02 | 2015-12-31 | 타녹스 인코퍼레이티드 | 신규한 ＩｇＥ 에피토프의 확인 |
| EP2511299A1 (en) | 2005-04-19 | 2012-10-17 | Seattle Genetics, Inc. | Humanized anti-CD70 binding agents and uses thereof |
| WO2008070593A2 (en) * | 2006-12-01 | 2008-06-12 | Seattle Genetics, Inc. | Variant target binding agents and uses thereof |
| CA2682927A1 (en) * | 2007-04-02 | 2008-10-16 | Amgen Fremont Inc. | Anti-ige antibodies |
| US8043620B2 (en) * | 2007-11-21 | 2011-10-25 | Amgen Inc. | Wise binding agents and epitopes |
| CA2818621A1 (en) * | 2010-11-24 | 2012-05-31 | Glaxo Group Limited | Multispecific antigen binding proteins targeting hgf |
| TW201334789A (zh) * | 2012-01-31 | 2013-09-01 | Genentech Inc | 抗ｉｇｅ抗體及其使用方法 |
| US10377827B2 (en) | 2012-06-21 | 2019-08-13 | Sorrento Therapeutics, Inc. | Antigen binding proteins that bind c-met |
| DK3157951T3 (da) | 2014-06-17 | 2020-08-17 | Academia Sinica | Humaniserede anti-ige-antistoffer, der tværbinder cd23 på b-lymfocytter, men ikke sensibiliserer mastceller |
| EP3448427A1 (en) * | 2016-04-29 | 2019-03-06 | CureVac AG | Rna encoding an antibody |
| EP3448874A4 (en) * | 2016-04-29 | 2020-04-22 | Voyager Therapeutics, Inc. | COMPOSITIONS FOR TREATING A DISEASE |
| KR20200113228A (ko) * | 2018-01-22 | 2020-10-06 | 지앙수 헨그루이 메디슨 컴퍼니 리미티드 | 항-4-1bb 항체, 이의 항원-결합 단편 및 이의 의학적 용도 |
-
2018
- 2018-01-05 JP JP2019537154A patent/JP7128191B2/ja active Active
- 2018-01-05 AU AU2018205484A patent/AU2018205484B2/en active Active
- 2018-01-05 CA CA3049967A patent/CA3049967C/en active Active
- 2018-01-05 EP EP18736220.7A patent/EP3565587A4/en active Pending
- 2018-01-05 US US16/475,614 patent/US11518818B2/en active Active
- 2018-01-05 WO PCT/US2018/012479 patent/WO2018129248A1/en not_active Ceased
-
2022
- 2022-08-18 JP JP2022130651A patent/JP7461420B2/ja active Active
- 2022-10-29 US US18/050,993 patent/US20230090487A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111601825A (zh) | 全人源的抗b细胞成熟抗原(bcma)单链抗体及其应用 | |
| NO20085362L (no) | Hoyaffinitets humane og humaniserte anti-alfa5 beta1-integrin funksjonsblokkerende antistoffer med redusert immunogenisitet | |
| WO2008134659A3 (en) | Antagonists to il-17a, il-17f, and il-23p19 and methods of use | |
| WO2018226580A3 (en) | ANTIBODIES SPECIFICALLY BINDING TO PD-1 AND THEIR METHODS OF USE | |
| JP2007525465A5 (cg-RX-API-DMAC7.html) | ||
| CN115943162A (zh) | 抗Claudin18.2抗体以及其用途 | |
| JP2015212284A5 (cg-RX-API-DMAC7.html) | ||
| JP2020521751A5 (cg-RX-API-DMAC7.html) | ||
| CN111542546A (zh) | 抗lag-3 抗体及其用途 | |
| BRPI0617485B8 (pt) | anticorpo anti-il-13 humano isolado, composição farmacêutica e uso do referido anticorpo | |
| WO2014194302A3 (en) | Antigen binding proteins that bind pd-1 | |
| JP2018526970A5 (cg-RX-API-DMAC7.html) | ||
| HRP20230197T1 (hr) | Nosači za dostavu izvedeni iz omotača adenovirusnog proteina | |
| AU2017297757A1 (en) | Novel antibodies specifically binding to zika virus epitopes and uses thereof | |
| HK1250990A1 (zh) | 凝血因子xi抗体及使用方法 | |
| WO2018050902A3 (en) | Multimers, tetramers & octamers | |
| EA201270813A1 (ru) | АНТИТЕЛА К N3pGlu БЕТА-АМИЛОИДНОМУ ПЕПТИДУ И ИХ ПРИМЕНЕНИЕ | |
| JP2011501176A5 (cg-RX-API-DMAC7.html) | ||
| EP2322551A3 (en) | Compositions comprising Anti-IGF-1R Antibodies and Methods for their Production | |
| WO2007036745A3 (en) | Interleukin-13 antibody composition | |
| CN110337449A (zh) | 抗pd-l1抗体及其应用 | |
| JP2016500250A5 (cg-RX-API-DMAC7.html) | ||
| WO2010018378A3 (en) | Vaccine comprising amb 1 a peptides for use in the treatment of ragweed allergy | |
| JP2017523200A5 (cg-RX-API-DMAC7.html) | ||
| WO2011003100A4 (en) | Compositions and methods for diagnosing and/or treating influenza infection |